╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Body Mass Index (BMI) >21 kg/m^2 and <35 kg/m^2    │ Body Mass Index (BMI) >21 kg/m^2 and <35 kg/m^2.   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Must have maximum age of 75 Years                  │ No Match                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Treated with a stable dose of one of the following │ No Match                                           │
│ for at least 3 months prior to screening:          │                                                    │
│ sulfonylurea/metformin combination therapy         │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have characteristics contraindicating metformin or │ Have characteristics contraindicating metformin or │
│ sulfonylurea use.                                  │ sulfonylurea use.                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have participated in this study previously, or any │ Have participated in this study previously, or any │
│ other study using exenatide or GLP-1 analogs.      │ other study using exenatide or GLP-1 analogs.      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Treated with a stable dose of one of the following │ No Match                                           │
│ for at least 3 months prior to screening:          │                                                    │
│ metformin >=1000 mg/day and sulfonylurea           │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ HbA1c between 7.1% and 11.0%, inclusive.           │ HbA1c between 7.1% and 11.0%, inclusive.           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have been treated with exogenous insulin for more  │ Have been treated with exogenous insulin for more  │
│ than 1 week within the 3 months prior to           │ than 1 week within the 3 months prior to           │
│ screening.                                         │ screening.                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Treated with a stable dose of one of the following │ No Match                                           │
│ for at least 3 months prior to screening: >=1000   │                                                    │
│ mg/day immediate-release metformin                 │                                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Must have minimum age of 21 Years                  │ No Match                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have used drugs for weight loss within 1 month of  │ Have used drugs for weight loss within 1 month of  │
│ screening.                                         │ screening.                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Have participated in an interventional, medical,   │ Have participated in an interventional, medical,   │
│ surgical, or pharmaceutical study within 30 days   │ surgical, or pharmaceutical study within 30 days   │
│ of screening.                                      │ of screening.                                      │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛